Fluoroquinolone Aortic Rupture & Antibiotic Injury Lawsuits
« Back to Blog

Fluoroquinolone Aortic Rupture & Antibiotic Injury Lawsuits

Ohio Product Liability Lawyer and Drug Recall Attorney reviewing cases of fluoroquinolone aortic rupture and aneurysm for plaintiffs nationwide


The U.S. Food and Drug Administration (FDA) has warned that fluoroquinolone antibiotics can increase the occurrence of aortic ruptures—tears in the aorta also called aortic dissections, which may lead to severe internal bleeding and death.

Fluoroquinolone aortic rupture and aneurysms are serious complications reported by medical professionals and have been studied over the last ten years. Adverse events reported to the FDA, in addition to evidence in observational studies, warn that patients administered common antibiotics, including Cipro, Avelox, Noroxin, Levaquin and others can lead to aortic dissection and other injuries including tendon rupture, peripheral neuropathy, and significant decreases in blood sugar.

New evidence of fluoroquinolone aortic rupture dictates that the drugs should be controlled more closely by doctors, and should not be used in patients at increased risk unless there are no other available treatment options. Patients at additional risk may include those with prior aortic aneurysms, high blood pressure, and the elderly. The FDA added a Black Box warning to certain antibiotics as a result of serious aortic dissection risks as well as added warnings about fluoroquinolone aortic rupture in prescribing information and patient medication guides for all fluoroquinolones.

Joe Lyon is an experienced pharmaceutical injury attorney and product liability lawyer representing plaintiffs nationwide in a wide variety of wrongful death and injury claims related to fluoroquinolone aortic rupture. 


Fluoroquinolone Aortic Rupture & FDA Warnings


Health care professionals are urged to avoid prescribing fluoroquinolone antibiotics to patients at risk of aortic aneurysm or with vascular diseases, hypertension, and elderly patients. Several studies have indicated that fluoroquinolone use is linked to an increased risk of aortic aneurysm or dissection. Published studies show fluoroquinolone aortic rupture rates of about twice the risk of those not taking this class of antibiotics. The FDA has mandated a black box warning on seven fluoroquinolone labels and prescribing information, including:


fluoroquinolone aortic rupture xeljanz fda warning medical device recall medical device defect lawyer
Antibiotic use may raise the risk of aortic rupture and other health complications.

If you or a loved one suffered an aneurysm or aortic dissection after taking a Fluoroquinolone antibiotic, and have questions about the legal remedies available to improve quality of life and medical care, contact The Lyon Firm at (800) 513-2403. You will speak directly with Mr. Lyon, and he will help you answer critical questions regarding fluoroquinolone cardiac injury.

Contact us today.

%d bloggers like this: